Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures.

Latest News

Share this

Author: Keystone Heart

CRT 2017

February 18-21, 2017     CRT 2017 is one of world’s leading interventional cardiology conferences and is being held in Washington, DC from February 18–21, 2017 at the Omni Shoreham Hotel. Stemming from a long history of success, this year’s CRT conference is destined to be the most...

JIM 2017

February 9-11, 2017   Keystone Heart Ltd. is excited to be participating in JIM 2017 in Milan, Italy February 9th – 11th. The main focus of this event is to have the opportunity to be informed about the very latest Innovation on Interventional Cardiology and to approach...

Delirium Significantly Associated with Brain Lesions in Patients Post-TAVR According to New Data Released at TCT 2016

According to New Data Released at TCT 2016 Delirium Significantly Associated with Brain Lesions in Patients Post-TAVR CAESAREA, Israel, and TAMPA, Florida --November 1, 2016 — Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, today...